Navigation Links
Breakthrough in drug trial offers hope for heart attack patients
Date:9/13/2010

New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.

Dr Robert Storey, Reader at the University of Sheffield and Consultant Cardiologist at Sheffield Teaching Hospitals, was the UK lead for international trials of a new drug, ticagrelor, which have been taking place over the last six years.

The new findings from one of these studies, the ONSET/OFFSET study, revealed that the platelet function in patients taking ticagrelor recovered much quicker after the drug is stopped, compared to the current gold standard drug, clopidogrel. This study also confirmed that breathlessness occurs as a side effect of ticagrelor but this is not associated with any harmful effects on lung or heart function.

The findings also include a new analysis of a previous trial looking at ticagrelor. This new examination of the PLATO trial, which was completed last year, shows that ticagrelor prevents 1 in 5 deaths after a heart attack, and patients who develop the adverse effect of breathlessness with ticagrelor still benefit from a lower risk of death compared to patients treated with clopidogrel for one year following a heart attack.

Dr Storey presented these latest results at the European Society of Cardiology (ESC) Congress 2010 on 29 August 2010 and was also involved in a 10,000 patient genetic substudy of the PLATO trial that was presented at the same time and published in The Lancet. This confirmed that patients treated with clopidogrel, who have a genetic variant that reduces the effect of this drug have a slightly higher risk following heart attack but ticagrelor is not affected by this variant and is still more effective than clopidogrel, regardless of a patient's genetic make-up.

Dr Storey has been involved with the development of the new drug, ticagrelor, for the past 12 years. 90 patients from Sheffield, with acute coronary s
'/>"/>

Contact: Lauren Anderson
l.h.anderson@sheffield.ac.uk
01-142-221-046
University of Sheffield
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel nanotechnology collaboration leads to breakthrough in cancer research
2. Breakthrough news involving migraine
3. In breakthrough, nerve connections are regenerated after spinal cord injury
4. A breakthrough in tuberculosis research
5. TGen partner, PBS-Bio, makes first breakthrough drug analysis
6. Research: Major breakthrough will revolutionize the screening and treatment of genetic diseases
7. Breakthrough In Liposuction Comes To New York's Capital District
8. Hair Loss Research Study Reveals Important Breakthrough in the Treatment of Male Pattern Baldness
9. Patients at high risk of recurrences of heart disease: Breakthrough in prevention
10. John Theurer Cancer Center offers breakthrough radiation measurement technology
11. Genome breakthrough allows scientists to identify and profile tumor cells from very small samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... Port Washington, NY (PRWEB) July 25, 2014 ... to protecting the rights of consumers comments on a ... the widow of a smoker $23.6 billion in punitive ... which manufactures Kool brand cigarettes. The case is Cynthia ... in 2008 in the Florida First Circuit Court, Escambia ...
(Date:7/25/2014)... study involving nearly 27,000 older adults on five continents ... pre-dementia based on a simple test that measures how ... People who tested positive for pre-dementia were twice as ... The study, led by scientists at Albert Einstein ... Montefiore Medical Center , was published online on July ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Hastings and ... offering discount attorney’s fees with regard to personal injury ... provide a wide range of legal services for those ... negligence of another individual or corporation. Free initial consultation ... the validity of a potential personal injury claim ...
(Date:7/25/2014)... York (PRWEB) July 25, 2014 As ... forward in U.S. courts, Bernstein Liebhard LLP notes that ... petition by the consumer advocacy group, Public Citizen, to ... In a letter dated May 1, 2014, and released ... the group’s petition for a ban on the marketing ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4
... Jan. 11, 2010 Amerigroup Corporation (NYSE: AGP ) ... quarter and the fiscal year ended December 31, 2009, at approximately ... 8:30 a.m. Eastern Time on the same day, Amerigroup,s management will ... information. , To listen to the call, dial 866-260-3161 (domestic) or ...
... Mass., Jan. 11 ( http://www.myprgenie.com ) -- Panel Intelligence, ... name back to MedPanel, LLC ("MedPanel"), the company,s original name ... name has been restored to reflect the company,s renewed, singular ... 2009. , "We are excited and proud to be independent ...
... could be used to guide treatment, researchers suggest , MONDAY, ... entire human genome has found a genetic variant associated with ... an important first step toward singling out cancers that need ... , "It is a proof of principle to show that ...
... , SC AG McMaster to Address ... , WASHINGTON, Jan. 11 South Carolina Attorney General ... into the constitutionality of the health care reform bill being ... press conference at 2:00 p.m. on Wednesday, January 13th, in ...
... WebMD Health Corp. (Nasdaq: WBMD ) today announced that executives ... Growth Stock Conference on Thursday, January 14, 2010 at 11:20 a.m. ... invited to listen to a live audio broadcast of the presentation ... www.wbmd.com (in the Investor Relations section). A replay of the ...
... Wake Forest University Baptist Medical Center and colleagues have ... cancer, proving the concept that genetic information may one ... guide treatment decisions. The research will be reported ... of the National Academy of Sciences . "This ...
Cached Medicine News:Health News:Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19 2Health News:Panel Intelligence Returns to MedPanel Name 2Health News:Genetic Marker for Aggressive Prostate Cancer Found 2Health News:Genetic Marker for Aggressive Prostate Cancer Found 3Health News:Genetic variant associated with aggressive form of prostate cancer 2
(Date:7/25/2014)... CHICAGO, Ill., July 25, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ... ended June 30, 2014. "This was another ... earnings per share above our original guidance and announced plans ...
(Date:7/24/2014)... , July 24, 2014  Parnell Pharmaceuticals ... compounds that will be added to Parnell,s already ... CIMTECH Pty Ltd, a biotechnology company. The compounds ... have shown promise in bone regeneration and dermal ... develop the compounds for the veterinary market with ...
(Date:7/24/2014)... Germany , and MARSEILLE, France ... , Exclusive global license from University of Tokyo ... next-generation sequencing (NGS) gene panels, for blood cancers  ... new test, indicate favorable prognosis for patients with bone ... sees potential for developing companion diagnostics to guide treatment ...
Breaking Medicine Technology:AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32AbbVie Reports Second-Quarter 2014 Financial Results 33AbbVie Reports Second-Quarter 2014 Financial Results 34AbbVie Reports Second-Quarter 2014 Financial Results 35AbbVie Reports Second-Quarter 2014 Financial Results 36
... First Patient Dosed in Phase 1 Trial of SBI-087, Trubion,s Next-Generation ... ... April 21 Trubion Pharmaceuticals,Inc. (Nasdaq: TRBN ) today announced ... WYE ), has initiated a Phase 1,clinical trial of SBI-087, a ...
... 21 Nostrum, a privately-held,company based in ... has,successfully completed its early, primate, proof-of-concept study ... as SMRX11. Nostrum,s,Symmetrix subsidiary, based in Singapore, ... license from the Institute of Microbial,Technology, Chandigarh, ...
Cached Medicine Technology:Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis 4Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2
MISTY OX® Gas Injection Nebulizer (GIN)...
... The Raindrop® medication nebulizer achieves optimum lung ... particle size range is 1.04-1.10 µ at ... or air outlet., ,As the world ... healthcare providers the assurance of proven technology ...
... for makeshift, modified nebulizer setups to deliver ... parts when your patient is critical? OMNI~MAX ... utmost in Heliox rescue therapy. In severe ... the standard of care in hospitals across ...
... World's smallest nebulizer utilizing Vibrating Mesh ... for patients suffering from Asthma, COPD ... the small product size and handy ... wherever life takes them. Powerful delivery ...
Medicine Products: